Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 6258Carcinoma, Renal Cell 1910Urinary Bladder Neoplasms 1669Kidney Neoplasms 929Breast Neoplasms 792Neoplasms 786Carcinoma, Transitional Cell 590Carcinoma, Non-Small-Cell Lung 522Neoplasm Metastasis 510Melanoma 484Ovarian Neoplasms 466Colorectal Neoplasms 451Lung Neoplasms 435Pancreatic Neoplasms 325Testicular Neoplasms 289Stomach Neoplasms 273Sarcoma 265Uterine Cervical Neoplasms 262Non-Muscle Invasive Bladder Neoplasms 262Head and Neck Neoplasms 241Colonic Neoplasms 217Esophageal Neoplasms 202Squamous Cell Carcinoma of Head and Neck 200Wilms Tumor 196Carcinoma, Hepatocellular 195Endometrial Neoplasms 188Recurrence 162Neuroblastoma 148Urologic Neoplasms 147Small Cell Lung Carcinoma 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Erythema Multiforme × Genitourinary × Clear all
NCT03044197 2019-06-05

Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy

The University of Texas Medical Branch, Galveston

Phase NA Completed
24 enrolled 8 charts
Genitourinary

Erythema Multiforme, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡